# PERIGON Japan Trial

> **NCT02686814** · NA · COMPLETED · sponsor: **Medtronic Cardiac Surgery** · enrollment: 25 (actual)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** 17mm MDT-2215 aortic valve bioprosthesis

## Key facts

- **NCT ID:** NCT02686814
- **Lead sponsor:** Medtronic Cardiac Surgery
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-05
- **Final completion:** 2022-07-15
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686814, "PERIGON Japan Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02686814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*